Just wondering with the recent cash infusion via the April secondary and what they will have to say today concerning their progress in their pipeline if they might make an attractive buyout in a rapidly consolidating and acquisition hungry Bio tech sector. Thoughts?
The implication is more than huge : (a) The drug actually works (b) Doctors and players know that there is no safety concerns
About to bust with news on Prostate Cancer Phase II trial and movement well about $1.00 100k shares = $100,000 when it hits $1.59, much more profit than this POS!
Sentiment: Strong Buy